HanchorBio Inc. (7827)
TWSE
141.00
+1.00 (+0.71%)
Real-time Data
01:00 AM
Day's Range
133.00142.00
52 wk Range
63.70187.00
Financial Statements - 7827 - HanchorBio Inc.
Revenue
312.22M
Net Income
-391.51M▲ 71.1%Net Margin -125.4%
EBITDA
-328.12M▲ 75.0%
Free Cash Flow
-337.16M▲ 46.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 312.22M | 0 | 0 | 3.36M |
| Cost of Goods | 0 | 0 | 0 | 1.31M |
| Gross Profit | 312.22M | 0 | 0 | 2.04M |
 Operating Expense | - | - | - | - |
| Operating Income | -367.60M | -952.11M | -538.05M | -512.32M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | -368.93M | -1.35B | -591.37M | -446.30M |
| Income Tax | 22.57M | 0 | - | - |
| Net Income | -391.51M | -1.35B | -591.37M | -446.30M |
| EPS Basic | - | -20.36 | -11.264586 | -1.626225 |
| EPS Diluted | - | -20.36 | -11.264586 | -1.626225 |
| Basic Shares Outstanding | - | 67.06M | 52.49M | 274.45M |
| Diluted Shares Outstanding | - | 67.06M | 52.49M | 274.45M |
| Ebit | -366.01M | -1.34B | -588.59M | -443.80M |
| Ebitda | -328.12M | -1.31B | -490.21M | -499.72M |
| Net Income Continuous Operations | -368.93M | -1.35B | -591.37M | -446.30M |
| Minority Interests | 114.79M | 0 | 17K | -22K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
